Autoimmune Disease Diagnosis Market

Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022

Report Code: MD 5936 Jan, 2018, by marketsandmarkets.com

[121 Pages Report] The autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 2.85 Billion in 2016 at a CAGR of 8.9%. The base year for this study is 2016 and the forecast period is 2017–2022.

The objectives of this study are as follows:

  • To define, describe, segment, and forecast the global market by product, test type, disease, end user, and region
  • To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market
  • To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the global market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation—by product, test type, disease, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources such as World Health Organization, National Institutes of Health, European Diagnostic, Manufacturers Association, World Bank, Centers for Disease Control and Prevention (CDC), American Association for Clinical Chemistry and American, and American Autoimmune Related Diseases Association have been used to identify and collect information useful for this extensive commercial study of the autoimmune disease diagnosis market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the global market. The breakdown of profiles of primaries is shown in the figure below:

Autoimmune Disease Diagnosis Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the autoimmune disease diagnosis market include Thermo Fisher Scientific (US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad (US), Inova Diagnostics (US), Trinity Biotech (Ireland), GRIFOLS (Spain), and Abbott (US).

Target Audience for this Report:

  • Manufacturers and vendors of autoimmune disease diagnosis products
  • Research associations related to autoimmune diseases
  • Pathologists and pathology laboratories
  • Various research and consulting firms
  • Distributors of autoimmune disease diagnosis products
  • Government bodies
  • Autoimmune disease diagnosis database and software providers
  • Venture capitalists

Scope of the Report:

This report categorizes the autoimmune disease diagnosis market into the following segments and subsegments:

Autoimmune Disease Diagnosis Market By Product and Service

  • Consumables and Assay Kits
  • Instruments
  • Services

Autoimmune Disease Diagnosis Market By Test Type

  • Routine Laboratory Tests
  • Inflammatory Markers
  • Autoantibodies and Immunologic Tests
  • Other Tests

Autoimmune Disease Diagnosis Market By Disease

  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Thyroiditis
  • Scleroderma
  • Sjögren’s syndrome
  • Other Diseases

Autoimmune Disease Diagnosis Market By End User

  • Clinical Laboratories
  • Hospitals
  • Other End Users

Autoimmune Disease Diagnosis Market By Region

  • North America
    • US
    • Canada
  • Europe
  • Asia
    • Japan
    • China
    • India
    • Rest of Asia
  • Rest of the World

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

The global autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%. The growing incidence of autoimmune diseases along population, technological advancements in analyzing devices, increasing access to medical insurance in the US, and increasing healthcare expenditure are key factors driving the growth of this market.

The global market is segmented by product and service, test type, disease, end user, and regions. By product and service, the global market is segmented into consumables and assay kits, instruments, and service. The consumables and assay kits segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the increasing adoption of consumables and assay kits and bulk buying of these products.

By test type, the market is classified into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. The routine laboratory tests segment is estimated to account for the largest share of the global autoimmune disease diagnosis market during the next five years. Increasing adoption of routine tests in the diagnosis of chronic disease is very high which is driving the growth of this market.

By disease, the market is classified systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome, thyroiditis, scleroderma, and other diseases. In 2017, the rheumatoid arthritis segment is estimated to account for the largest share of the global market. The growth of this segment is mainly driven by the increasing incidences of the disease.

On the basis of end user, the autoimmune disease market is segmented into clinical laboratories, hospitals, and other end users. In 2017, the clinical laboratories segment is estimated to account for the largest share of the global market. Growth in the number of clinical laboratories coupled with better accessibility and availability of instruments are major factors driving the growth of this end-user segment.

Autoimmune Disease Diagnosis Market

The global autoimmune disease diagnosis market is dominated by North America, followed by Asia. North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.
The factors such as high degree of consolidation, high cost of instruments, and complex regulatory framework for the approval of new products may restrain market growth.

Major industry players launched innovative products to maintain and improve their position in the autoimmune disease diagnosis market. Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), HYCOR Biomedical (US), Siemens AG (Germany), Bio-Rad Laboratories, Inc. (US), and Abbott Laboratories (US) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders have products for all end users in this market, a strong geographical presence, and focus on continuous product innovations.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Definition
    1.3 Study Scope
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Data Triangulation

3 Executive Summary (Page No. - 23)

4 Premium Insights (Page No. - 27)
    4.1 Attractive Market Opportunities in Autoimmune Disease Diagnosis Market
    4.2 Asia: Market, By Test Type
    4.3 Geographical Snapshot of the Global Market
    4.4 Global Market, By End User

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Incidence and Large Economic Burden of Autoimmune Diseases
                    5.2.1.2 Increasing Access to Medical Insurance in the US
           5.2.2 Restraints
                    5.2.2.1 High Capital Requirements
           5.2.3 Opportunities
                    5.2.3.1 Growth Opportunities in Emerging Countries
                    5.2.3.2 Increasing Number of Awareness Programs for Autoimmune Diseases
           5.2.4 Trends
                    5.2.4.1 Growth in the Number of Reagent Rental Agreements

6 Autoimmune Disease Diagnosis Market, By Product & Service (Page No. - 35)
    6.1 Introduction
    6.2 Consumables and Assay Kits
    6.3 Instruments
    6.4 Services

7 Autoimmune Disease Diagnosis Market, By Test Type (Page No. - 40)
    7.1 Introduction
    7.2 Routine Laboratory Tests
    7.3 Inflammatory Markers
    7.4 Autoantibodies and Immunologic Tests
    7.5 Other Tests

8 Autoimmune Disease Diagnosis Market, By Disease (Page No. - 45)
    8.1 Introduction
    8.2 Rheumatoid Arthritis
    8.3 Systemic Lupus Erythematosus
    8.4 Sjögren’s Syndrome
    8.5 Thyroiditis
    8.6 Scleroderma
    8.7 Other Diseases

9 Autoimmune Disease Diagnosis Market, By End User (Page No. - 52)
    9.1 Introduction
    9.2 Clinical Laboratories
    9.3 Hospitals
    9.4 Other End Users

10 Autoimmune Disease Diagnosis Market, By Region (Page No. - 57)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
     10.4 Asia
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia (RoA)
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 85)
     11.1 Overview
     11.2 Market Share Analysis, 2016
     11.3 Competitive Scenario
             11.3.1 Product Launches
             11.3.2 Partnerships
             11.3.3 Acquisitions
             11.3.4 Collaborations

12 Company Profiles (Page No. - 89)
(Business Overview, Products Offered, MnM View.)*
     12.1 Siemens
     12.2 Abbott
     12.3 Thermo Fisher Scientific
     12.4 Danaher
     12.5 Bio-Rad Laboratories
     12.6 GRIFOLS
     12.7 Trinity Biotech
     12.8 Inova Diagnostics
     12.9 HYCOR Biomedical
     12.10 Euroimmun
     12.11 Protagen

*Business Overview, Products Offered, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 112)
     13.1 Insights From Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (64 Tables)

Table 1 Autoimmune Disease Diagnosis Market, By Products & Services,, 2015–2022 (USD Million)
Table 2 Autoimmune Disease Diagnosis Consumables and Assay Kits Market,, By Region, 2015–2022 (USD Million)
Table 3 Autoimmune Disease Diagnosis Instruments Market, By Region,, 2015–2022 (USD Million)
Table 4 Autoimmune Disease Diagnosis Services Market, By Region,, 2015–2022 (USD Million)
Table 5 Global Market, By Test Type,, 2015–2022 (USD Million)
Table 6 Global Market for Routine Laboratory Tests, By Region, 2015–2022 (USD Million)
Table 7 Global Market for Inflammatory Markers,, By Region, 2015–2022 (USD Million)
Table 8 Global Market for Autoantibodies and Immunologic Tests, By Region, 2015–2022 (USD Million)
Table 9 Global Market for Other Tests, By Region, 2015–2022 (USD Million)
Table 10 Autoimmune Disease Diagnosis Market, By Disease,, 2015–2022 (USD Million)
Table 11 Global Market for Rheumatoid Arthritis,, By Region, 2015–2022 (USD Million)
Table 12 Global Market for Sle, By Region,, 2015–2022 (USD Million)
Table 13 Global Market for Sjögren’s Syndrome,, By Region, 2015–2022 (USD Million)
Table 14 Global Market for Thyroiditis, By Region,, 2015–2022 (USD Million)
Table 15 Global Market for Scleroderma, By Region, 2015–2022 (USD Million)
Table 16 Global Market for Other Diseases, By Region, 2015–2022 (USD Million)
Table 17 Global Market, By End User,, 2015–2022 (USD Million)
Table 18 Global Market for Clinical Laboratories,, By Region, 2015–2022 (USD Million)
Table 19 Global Market for Hospitals, By Region,, 2015–2022 (USD Million)
Table 20 Global Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 21 Global Market, By Region,, 2015–2022 (USD Million)
Table 22 North America: Autoimmune Disease Diagnosis Market, By Country, 2015–2022 (USD Million)
Table 23 North America: Market, By Product, & Service, 2015–2022 (USD Million)
Table 24 North America: Market, By Test Type, 2015–2022 (USD Million)
Table 25 North America: Market, By Disease, 2015–2022 (USD Million)
Table 26 North America: Market, By End User, 2015–2022 (USD Million)
Table 27 US: Autoimmune Disease Prevalence, 2016
Table 28 US: Market, By Product & Service,, 2015–2022 (USD Million)
Table 29 US: Market, By Test Type,, 2015–2022 (USD Million)
Table 30 US: Market, By Disease,, 2015–2022 (USD Million)
Table 31 US: Market, By End User,, 2015–2022 (USD Million)
Table 32 Canada: Autoimmune Disease Diagnosis Market, By Product & Service, 2015–2022 (USD Million)
Table 33 Canada: Market, By Test Type,, 2015–2022 (USD Million)
Table 34 Canada: Market, By Disease,, 2015–2022 (USD Million)
Table 35 Canada: Market, By End User,, 2015–2022 (USD Million)
Table 36 Europe: Market, By Product & Service, 2015–2022 (USD Million)
Table 37 Europe: Market, By Test Type,, 2015–2022 (USD Million)
Table 38 Europe: Market, By Disease,, 2015–2022 (USD Million)
Table 39 Europe: Market, By End User,, 2015–2022 (USD Million)
Table 40 Asia: Autoimmune Disease Diagnosis Market, By Country,, 015–2022 (USD Million)
Table 41 Asia: Market, By Product & Service, 2015–2022 (USD Million)
Table 42 Asia: Market, By Test Type,, 2015–2022 (USD Million)
Table 43 Asia: Market, By Disease,, 2015–2022 (USD Million)
Table 44 Asia: Market, By End User,, 2015–2022 (USD Million)
Table 45 China: Market, By Product & Service, 2015–2022 (USD Million)
Table 46 China: Market, By Test Type,, 2015–2022 (USD Million)
Table 47 China: Market, By Disease,, 2015–2022 (USD Million)
Table 48 China: Market, By End User,, 2015–2022 (USD Million)
Table 49 Japan: Autoimmune Disease Diagnosis Market, By Product & Service, 2015–2022 (USD Million)
Table 50 Japan: Market, By Test Type,, 2015–2022 (USD Million)
Table 51 Japan: Market, By Disease,, 2015–2022 (USD Million)
Table 52 Japan: Market, By End User,, 2015–2022 (USD Million)
Table 53 India: Market, By Product & Service, 2015–2022 (USD Million)
Table 54 India: Market, By Test Type,, 2015–2022 (USD Million)
Table 55 India: Market, By Disease,, 2015–2022 (USD Million)
Table 56 India: Market, By End User,, 2015–2022 (USD Million)
Table 57 RoA: Autoimmune Disease Diagnosis Market, By Product & Service, 2015–2022 (USD Million)
Table 58 RoA: Market, By Test Type,, 2015–2022 (USD Million)
Table 59 RoA: Market, By Disease,, 2015–2022 (USD Million)
Table 60 RoA: Market, By End User,, 2015–2022 (USD Million)
Table 61 RoW: Market, By Product & Service, 2015–2022 (USD Million)
Table 62 RoW: Market, By Test Type,, 2015–2022 (USD Million)
Table 63 RoW: Market, By Disease,, 2015–2022 (USD Million)
Table 64 RoW: Market, By End User,, 2015–2022 (USD Million)
 

List of Figures (36 Figures)
 
Figure 1 Market Segmentation
Figure 2 Research Design
Figure 3 Autoimmune Disease Diagnosis Market: Bottom-Up Approach
Figure 4 Global Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Assumptions
Figure 7 Global Market, By Products & Services, , 2017 vs 2022 (USD Million)
Figure 8 Global Market, By Test Type, , 2017 vs 2022 (USD Million)
Figure 9 Autoimmune Disease Diagnosis Market, By Disease, , 2017 vs 2022 (USD Million)
Figure 10 Global Market, By End User, , 2017 vs 2022 (USD Million)
Figure 11 Global Market, By Region, , 2017 vs 2022 (USD Million)
Figure 12 High Incidence & Large Economic Burden of Autoimmune Diseases—Major Factor Expected to Drive Market Growth
Figure 13 Routine Laboratory Tests Segment to Dominate the Asian Autoimmune Disease Diagnosis Market in 2017
Figure 14 North America to Account the Highest Market Share in 2017
Figure 15 Clinical Laboratories to Dominate the Global Market in 2017
Figure 16 Autoimmune Disease Diagnosis Market: Drivers, Restraints, Opportunities, & Trends
Figure 17 Consumables and Assay Kits to Form the Largest Product Segment, in 2017
Figure 18 Routine Laboratory Tests to Form the Largest Test Type Segment, in 2017
Figure 19 Rheumatoid Arthritis to Form the Largest Disease Segment in 2017
Figure 20 Clinical Laboratories to Form the Largest End-User Segment in 2017
Figure 21 Global Market, By Region, , 2017 vs 2022 (USD Million)
Figure 22 North America: Market Snapshot
Figure 23 Consumables & Assay Kits to Dominate the North American Market, By Product & Service, in 2017
Figure 24 Routine Laboratory Tests to Dominate the European Autoimmune Disease Diagnosis Market in 2017
Figure 25 Asia: Market Snapshot
Figure 26 Rheumatoid Arthritis to Dominate the Asian Market in 2017
Figure 27 Clinical Laboratories Segment to Register the Highest Growth Rate in the RoW Market Between 2017 & 2022
Figure 28 Product Launches, the Most Adopted Growth Strategy From , 2014 to 2017
Figure 29 Shares of Top Companies in the Global Market 2016
Figure 30 Siemens: Company Snapshot
Figure 31 Abbott: Company Snapshot
Figure 32 Thermo Fisher Scientific: Company Snapshot
Figure 33 Danaher: Company Snapshot
Figure 34 Bio-Rad Laboratories: Company Snapshot
Figure 35 GRIFOLS: Company Snapshot
Figure 36 Trinity Biotech: Company Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 5936
Published ON
Jan, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Autoimmune Disease Diagnosis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved